UChicago Medicine Comprehensive Cancer Center

Hepatic Artery Infusion (HAI) Pump Chemotherapy

Surgeons working in an operating room.

An Innovative Treatment from a Leading Cancer Center

Hepatic artery infusion (also called hepatic arterial infusion pump chemotherapy, or HAI) is an innovative treatment for patients with certain metastatic colorectal and bile duct cancers that affect the liver. It’s a powerful tool for doctors to use to treat liver tumors and to further tailor treatment plans.

With the help of an implantable pump, HAI delivers high doses of chemotherapy directly to the liver. It shrinks tumors with fewer side effects than traditional chemotherapy given through a vein.

The University of Chicago Medicine is the only hospital in Illinois and is among a select number in the country to offer this advanced treatment.

Hepatic Artery Infusion (HAI) Pump Chemotherapy for Liver Metastases

Hepatic artery infusion pump chemotherapy, or HAI, is an advanced treatment for tumors that have spread to the liver due to metastatic colorectal cancer or metastatic bile duct cancer. HAI is a powerful tool to shrink liver tumors and reduces the risk of tumor recurrence.

Hepatic Artery Infusion Pump FAQs

Here are answers to commonly asked questions about the treatment and the pump.

An Innovator in Hepatic Artery Infusion Research

At UChicago Medicine, our team is conducting a clinical trial of HAI for patients with metastatic colorectal cancer that has spread to the liver but who are not candidates for surgery. We also plan to study other chemotherapy drugs to use with the pump as well as other types of patients who might benefit from this treatment.

UChicago Medicine is also part of an international consortium of academic medical centers studying survival, quality of life and other outcomes for patients who have been treated with HAI. Through this collaborative effort, we aim to make HAI as safe and effective as possible and more widely available to patients who could benefit.

Why Should I Choose UChicago Medicine for Cancer Care?

The University of Chicago Medicine is home to a National Cancer Institute-designated Comprehensive Cancer Center, where patients have access to HAI as well as other innovative treatments and clinical trials that are not widely available at other hospitals.

We also offer other life-extending treatments to people with stage 4 cancers through our Limited Metastatic Cancer Program.

Hepatic Artery Infusion Program Leader

 

Request an Appointment for Cancer Care

The information you provide in this form will enable us to assist you as efficiently as possible. A representative will contact you within one to two business days to help you schedule an appointment. 

To speak to someone directly, please call 1-855-702-8222. If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

 
For Referring Physicians

To refer a patient for cancer care, please call UCM Physician Connect at 1-800-824-2282

 
By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.